Add a Clinically-Validated Tinnitus Treatment to Your Practice
Your patients with tinnitus need more than a referral elsewhere. Neuromonics gives your practice a complete, evidence-backed tinnitus treatment solution — delivered through an app your patients use at home, monitored through your provider portal, and backed by 20 years of peer-reviewed clinical evidence. No additional equipment. No lengthy in-clinic sessions. A new revenue stream and a new reason for patients to stay loyal to your practice.
What the Neuromonics Platform Gives You
1
Remote care flexibility
Your patients complete treatment at home using the Neuromonics app on their phone. You monitor their progress, compliance, and outcomes through the provider portal without requiring additional appointments. Extend your tinnitus care beyond the clinic walls.
2
Audiogram-personalized treatment
The Neuromonics algorithm personalizes the acoustic stimulation to each patient's specific hearing profile — the same profile you already have from their audiogram. No additional testing required. Upload their audiogram and the app does the rest.
3
Analytics dashboard
Track every patient's usage, compliance, and self-reported outcomes in real time. See which patients are engaging consistently and which need a check-in. Generate outcome reports for insurance documentation or referral letters.
4
Treatment controls
Adjust treatment parameters for individual patients through the provider portal. Advance patients through treatment phases, modify acoustic settings, and personalize the program without the patient needing to come in.
5
Ongoing clinical support
Access Neuromonics clinical training, patient education materials, and a dedicated support team. We provide everything you need to confidently offer tinnitus treatment — including patient handouts, consultation frameworks, and clinical protocols.
How Neuromonics Complements — Not Competes With — Your Hearing Aid Practice
We understand the concern. Hearing aids are a significant revenue driver for most audiology practices, and any new treatment program needs to make business sense. Here is the reality: tinnitus and hearing loss coexist in approximately 80% of cases. Hearing aids address the hearing loss. Neuromonics addresses the tinnitus. They are complementary, not competing. Offering both means your tinnitus patients stay in your practice rather than being referred elsewhere, your hearing aid patients get a complete tinnitus solution alongside their amplification, and you generate additional revenue from tinnitus treatment without reducing hearing aid sales.
The clinical case for combining both
Multiple clinical studies show that patients who use hearing aids combined with Neuromonics sound therapy achieve better tinnitus outcomes than either treatment alone. For patients with co-occurring hearing loss and tinnitus, prescribing both is the clinically optimal approach — and the strongest business case for your practice.
Clinical Evidence Your Patients Will Trust
When a patient asks why they should trust this treatment, you need an answer backed by evidence — not just a brochure. Neuromonics has the most extensive clinical evidence base of any tinnitus treatment currently available: 10 peer-reviewed studies, 1,033+ patients, 83% average success rate, seven independent studies. You can refer patients with confidence.
83%
Average success rate
Across 10 clinical studies
1,033+
Patients studied
US & Australian medical centers
96%
Highest single-study result
Hollywood VA (Veterans Affairs)
| Study | Subjects | Location | Type | Success* |
|---|
| Hollywood VA | 35 | Veterans Affairs US | Independent | 96% |
| Private Practice | 470 | Australia | Neuromonics | 92% |
| T2 – NTT vs SOC | 50 | Australia | Neuromonics | 90% |
| Tavori TRI | 25 | Australia | Independent | 90% |
| T3 – Phase 1 vs 2 | 35 | Australia | Neuromonics | 86% |
| CALM Study | 51 | United States | Independent | 81% |
| Lions Ear Institute | 29 | Australia | Independent | 75% |
| Tavora AAA | 70 | US / Australia | Independent | 75% |
| Australian Veterans | 50 | Veterans Affairs AU | Independent | 74% |
| Oregon Tinnitus | 24 | United States | Independent | 72% |
| Total / Average | 1,033 | | | 83% |
*Success = clinically significant reduction in tinnitus disturbance. 10 studies across US & Australian medical centers, 2007–2010.
🏥
Independent verification
7 of 10 studies conducted by independent researchers — not Neuromonics
👨⚕️
Veterans Affairs validated
96% success at Hollywood VA — among the most rigorous real-world settings
📊
Largest real-world study
470-patient private practice study — 92% success rate
Do I need training to offer Neuromonics? +
Is What does the patient experience look like in my practice? permanent?+
How does Neuromonics compare to TRT in clinical time?+
What results should I tell my patients to expect?+
Does Neuromonics integrate with hearing aids? +
Will offering Neuromonics reduce my hearing aid revenue?+
What ongoing support does Neuromonics provide?+
Ready to offer your patients a tinnitus solution?
Join the audiologists and hearing care professionals who use Neuromonics every day. Platform access, clinical training, and patient support included.
Sign Up as a Provider →
